Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.
5. In fifth position, is our cover story from the latest issue from Nalla, looking at some useful digital and brand trends for the pharmaceutical sector.
Missing a trick? Four useful digital trends for the pharma sector
4. Results showing promise for PARP-inhibitor combination therapy in prostate cancer makes it onto the list at number four.
Results show promise for PARP-inhibitor combination therapy in prostate cancer
3. Coming in third place is our very own round up of some of the innovations coming out of ACHEMA 2018 — a full list of relevant articles can be found here.
Processing it all, day 1 — some of the key innovations from the show floor at ACHEMA 2018
2. Runner up this week is the news from Wasdell Group, which is investing £500k into a new lab at its Newcastle site.
Wasdell Group invests £500k in new lab at Newcastle site
1. Taking the top spot for the week is the announcement that NICE has published positive guidance for Tremfya for plaque psoriasis.